egtazic acid has been researched along with diclofenac in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boelsterli, UA; Gupta, R; Lim, MS; Lim, PL | 1 |
Boelsterli, UA; Latchoumycandane, C; Pun, PB; Siu, WP | 1 |
2 other study(ies) available for egtazic acid and diclofenac
Article | Year |
---|---|
Critical role of free cytosolic calcium, but not uncoupling, in mitochondrial permeability transition and cell death induced by diclofenac oxidative metabolites in immortalized human hepatocytes.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aryl Hydrocarbon Hydroxylases; Calcium; Cell Line, Transformed; Cyclosporine; Cytochrome P-450 CYP2C9; Cytosol; Diclofenac; Dose-Response Relationship, Drug; Drug Antagonism; Egtazic Acid; Hepatocytes; Humans; Membrane Potentials; Mitochondria, Liver; Mitochondrial Membranes; Oxidation-Reduction; Permeability; Sulfaphenazole; Superoxides; Uncoupling Agents | 2006 |
Bax-mediated mitochondrial outer membrane permeabilization (MOMP), distinct from the mitochondrial permeability transition, is a key mechanism in diclofenac-induced hepatocyte injury: Multiple protective roles of cyclosporin A.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; BH3 Interacting Domain Death Agonist Protein; Calcium; Cell Line; Chelating Agents; Cyclophilins; Cyclosporine; Cytoprotection; Diclofenac; Egtazic Acid; Hepatocytes; Humans; MAP Kinase Kinase Kinase 5; Mitochondria, Liver; Mitochondrial Membranes; Mitochondrial Proteins; Permeability; RNA, Small Interfering; Thioredoxins | 2008 |